» Authors » Katalin Sas

Katalin Sas

Explore the profile of Katalin Sas including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 431
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nemeth T, Pecsy B, Geczi T, Sas K, Szpisjak L, Rieth A, et al.
Orv Hetil . 2019 Dec; 161(1):33-38. PMID: 31884815
Castleman disease is a rare lymphoproliferative disease the exact cause of which is not known. The diagnosis is based on the adequate histological examination. While in the unifocal form, the...
2.
Pozsegovits K, Szabo G, Szupera Z, Nagy P, Nemeth L, Kondakor I, et al.
Ideggyogy Sz . 2019 Dec; 72(11-12):407-412. PMID: 31834684
Background And Purpose: Acute mortality rate of stroke in Hungary is significantly higher than in Western Europe, which is likely to be partially attributable to suboptimal treatment. Methods: We examined...
3.
Sztriha L, Seres E, Sas K, Vecsei L
EJIFCC . 2018 Jul; 15(3):58-60. PMID: 29988931
No abstract available.
4.
Sas K, Szabo E, Vecsei L
Molecules . 2018 Jan; 23(1). PMID: 29342113
In this review, the potential causes of ageing are discussed. We seek to gain insight into the main physiological functions of mitochondria and discuss alterations in their function and the...
5.
Marton I, Posfai E, Csomor A, Vecsei L, Borbenyi Z, Sas K
Pathol Oncol Res . 2017 Oct; 25(1):439-442. PMID: 29027624
No abstract available.
6.
Posfai E, Marton I, Szoke A, Borbenyi Z, Vecsei L, Csomor A, et al.
J Neurol Sci . 2013 Nov; 336(1-2):260-2. PMID: 24183283
Background: Our aim was to assess the incidence and the special characteristics of stroke, as a severe complication of patients diagnosed with essential thrombocythemia (ET). Methods: A retrospective analysis was...
7.
Vadasz D, Sztriha L, Sas K, Vecsei L
Ideggyogy Sz . 2013 Apr; 66(1-2):15-22. PMID: 23607225
Recent meta-analyses have indicated that patients with vascular disease demonstrated by laboratory tests to be aspirin or clopidogrel-resistant are at an increased risk of major vascular events. The suggested mechanisms...
8.
Vadasz D, Sztriha L, Sas K, Vecsei L
Ideggyogy Sz . 2013 Jan; 65(11-12):377-85. PMID: 23289172
Aspirin and clopidogrel are well established as antiplatelet medication in the treatment of atherothrombotic vascular disease. However, despite treatment, a substantial number of patients experience recurrent ischemic episodes, referred to...
9.
Sas K, Pardutz A, Toldi J, Vecsei L
J Neurol Sci . 2010 Sep; 299(1-2):55-65. PMID: 20828765
Dementia, stroke and migraine are very common neurological disorders affecting a large percentage of the population, and leading to a high degree of disability. Often, adequate therapy is not available....
10.